Search NovaTechs

NovaSeal®
Interventional Radiology
Clinical Trials
Embolization

NovaTechs: Where Ideas Save Lives

We are here to revolutionize interventional radiology, with a focus on transcatheter embolization— a vital technique for addressing hypervascular tumors and cutting off their blood supply.

2020

Founded in Netherlands

2023

NovaSeal® Launched

100%

Bio-based Materials

0

Toxic Solvents

Overview of Technology

Revolutionary gel-based solutions for interventional radiology

In situ gels are specialized formulations that can be administered in a liquid form and transform into a gel, usually in response to physiological changes in temperature, etc. This remarkable feature allows for the controlled and sustained release of therapeutic/radiographic agents, ensuring that medications are delivered effectively to the targeted site.

Temperature-responsive
Targeted delivery
Sustained release
Bio-based materials
Liquid Form Gel State

Discover Our Innovative Gel Solutions

Explore our cutting-edge technology and revolutionary approach to cancer treatment.

Coming Soon

Learn How Our Gels Can Change Patients' Health

Understand the science behind our gel-based technology and its impact on patient outcomes.

Coming Soon

Join a Clinical Trial

Participate in our groundbreaking research and help advance cancer treatment technology.

Coming Soon

Applications

NovaSeal® is designed to treat a range of conditions requiring precise blood vessel blockage

Hepatocellular Carcinoma

Targeted treatment for liver cancer with minimal damage to healthy tissue.

Renal Cell Carcinoma

Effective embolization for kidney cancer treatment.

Brain Tumors

Precise treatment for hypervascular brain tumors.

Uterine Fibroids

Non-surgical treatment for uterine fibroids.

Benign Prostate Hyperplasia

Minimally invasive treatment for prostate conditions.